Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Vertex and Bristol-Myers Squibb to conduct phase II studies of VX-135 and daclatasvir

April 8, 2013

Covis Pharma to acquire U.S. rights to several sanofi-aventis drugs

April 8, 2013

Astellas to collaborate with Ambrx on antibody-drug conjugates for cancer

April 8, 2013

X-Body Biosciences forms therapeutic antibody alliance

April 8, 2013

Merck Serono and BioMed X enter collaboration to conduct research projects in oncology

April 5, 2013

BIND Therapeutics and Pfizer to develop multiple Accurins

April 5, 2013

Ra Pharmaceuticals collaborates with Merck & Co. on Cyclomimetics

April 5, 2013

Elan closes Tysabri transaction

April 4, 2013

Wakamoto and DWTI sign license agreement for antiglaucoma agent

April 4, 2013

Dainippon Sumitomo gains rights to two Edison Pharmaceuticals compounds

April 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...